Medical News Bulletin - Daily Medical News, Health News, Clinical Trials And Clinical Research, Medical Technology, Fitness And Nutrition News–In One Place

Recently heard Joe Rogen adjacent podcasters discussing COVID-19 vaccines and their effectiveness and safety? Wondering whether that guy at the bar who keeps insisting that COVID shots are nonsense might have a point? So, is it worth getting a COVID-19 booster in 2026 and onwards? If you are looking for evidence-based information about the efficacy […]

The post Is it worth getting a COVID-19 Booster in 2026? appeared first on Medical News Bulletin.

The FDA has approved oral Utebzi tablets as a treatment for complicated urinary tract infections, including pyelonephritis, in adults with “limited or no alternative oral treatment options,” the agency announced.
Utebzi (tebipenem pivoxil, GSK and Spero Therapeutics) is the first oral carbapenem antibiotic approved for complicated UTIs in the United States. It is the second complicated UTI medication approved by the FDA this month, the other being Zaynich (cefepime/zidebactam, Wockhardt), an IV formulation.
“With antibiotic resistance continuing to rise, patients and health care professionals

PHOENIX — Johnson & Johnson announced at Optometry’s Meeting that its Acuvue Oasys 1-Day for Astigmatism contact lenses will be available this summer in parameters up to –2.75 D of cylinder.
“Oasys 1-Day for Astigmatism ... provides really stable, consistent vision throughout the day, and with this expanded parameter range, we’re now able to serve more patients with Oasys 1-Day and give them that reliable, comfortable, stable vision from the beginning of the day to the end of the day,” Erin Rueff, OD, PhD, FAAO, Dipl AAO, associate director of professional education at Johnson &

New HIV infections and AIDS-related deaths decreased significantly since 2010, but the goal to end HIV/AIDS as a public health threat by 2030 remains at risk because of funding cuts and setbacks in prevention, according a new UNAIDS report.
Angeli Achrekar, PhD, deputy executive director at UNAIDS, noted that there has been a series of recent global public health crises, including COVID-19, mpox and Ebola.
“But with the longstanding HIV pandemic, where the world has made remarkable progress, we are seeing the perfect storm growing,” Achrekar told reporters during a press conference. “This storm

Editor’s note: This is a developing story. Please check back soon for updates.
Bayer has acquired Perfuse Therapeutics, including the full rights to the PER-001 intravitreal implant, which is in development for glaucoma and diabetic retinopathy.
According to a press release, the transaction carries a potential value of up to $2.45 billion, with Bayer paying $300 million upfront. Phase 2 development for PER-001, a sustained-release small molecule endothelin receptor antagonist, is currently underway.
“This acquisition strengthens Bayer’s pharmaceutical pipeline and strategically fits with Bayer’s

The FDA approved Skinvive by Juvéderm for the treatment of neck wrinkles in adults aged 21 years or older, Allergan Aesthetics announced in a press release.
This approval makes Skinvive by Juvéderm (Allergan Aesthetics) the first and only hyaluronic acid injectable indicated to reduce the appearance of neck lines, according to the release.
There are many causes for neck wrinkles, including natural aging, sun damage, weight loss, or the modernly coined term “tech-neck,” where lines form in the neck region due to constantly looking down at computers, phones, tablets and books. According to the

NASHVILLE, Tenn. — A Gulf Coast hospital reported a nearly 90% decline in surgical site infections related to hysterectomy procedures after implementing metronidazole as a mandatory preoperative antibiotic.
An infection prevention team from Touro Infirmary — a 300-plus-bed acute care facility in New Orleans — summarized the results of an internal review of the practice at the Association for Professionals in Infection Control and Epidemiology annual meeting on Monday.
Elisia P. Dupre, MPH, CIC, an infection preventionist from Touro, told a crowded conference room that her team identified gaps

For the modern orthopedic surgeon, financial success is often a byproduct of decades of specialized training and a commitment to clinical excellence.
However, this high level of compensation frequently places physicians in a unique tax position: their income exceeds the thresholds for many traditional wealth-building tools, most notably the direct Roth IRA contribution. While the IRS effectively “locks the front door” to these tax-free accounts once a certain income level is reached, a more sophisticated entry point remains available.
For the physician balancing a demanding surgical volume with

LAS VEGAS — A prosthetic capsular bag may help solve issues with fixating a secondary IOL, according to a speaker at Clinical Trials at the Summit.
Frank Brodie, MD, MBA, of University of California, San Francisco, told Healio that while surgeons have options when it comes to secondary IOL fixation, many come with complications.
{{VIDEO}}
“This isn’t about the lens,” Brodie told Healio. “This is a problem with a capsule.”
Brodie presented the findings from a first-in-human study of the LensOne (Long Bridge Medical) prosthetic capsular bag. The device includes IOL housing, which Brodie said can

NEW ORLEANS — Feedback from home dialysis nurses may help inform practical, organizational and national strategies to address nursing shortages, according to data presented at the National Kidney Foundation Spring Clinical Meetings.
Alexis Martin, MA, research analyst at Arbor Research Collaborative for Health, and colleagues held semi-structured interviews with 23 home dialysis nurses in the U.S. to gather perspectives on factors contributing to the nursing shortage and how to address them. The highest proportions of home dialysis nurses were staff nurses (83%), worked at a large dialysis